Breath Device to Detect Blood Sugar Changes in Teens
Part of Hormones & metabolism clinical trials.
This study tests if a breath device can spot high or low blood sugar in teens with type 1 diabetes without a fingerstick. Participants will use the device a few times and share their CGM data.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 12 and 19 years old.
- You must have type 1 diabetes.
- You must use a Dexcom G6 or G7 CGM that is working steadily for at least 12 hours and won't need to be changed within the next day.
- You must be willing to share your CGM data for the study.
- No one else in your household should have type 1 or type 2 diabetes.
- You must live in or near Indianapolis, Indiana.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new breath-based sensor to detect low or high blood sugar (hypoglycemia or hyperglycemia) in people with type 1 or type 2 diabetes. It might offer a non-invasive way to monitor glucose levels.
This study uses a wearable sensor (like a smartwatch) to track your body's signals when blood sugar drops low. The goal is to understand low blood sugar patterns better, which may help improve prevention and treatment.
This study tests using a continuous glucose monitor (CGM) in teenagers with type 1 diabetes in the Dominican Republic. The device tracks blood sugar levels around the clock to help manage their diabetes better. Participants will get support and education over about 15 months.
This study tests a new continuous glucose monitor that checks your blood sugar levels in real time. It aims to see how accurate and safe it is for people with diabetes.
This trial tests if using a continuous glucose monitor (a small sensor that checks your sugar levels without fingersticks) helps young adults manage type 2 diabetes better. You will wear the sensor and use a phone app to track your glucose.
This trial tests a new continuous glucose monitor (CGM) designed to help manage blood sugar levels. You will wear the device for 15 days and attend three clinic visits to see how well it works.
Hear when a new Diabetes trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.